Sirolimus
NDC 55111-654, Sirolimus, tablet, from Dr. Reddy's Laboratories Limited.
- Product NDC
- 55111-654
- Status
- Listed
- Labeler
- Dr. Reddy's Laboratories Limited
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA201578
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/55111-654 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SIROLIMUS2 mg/1
Pharmacologic classes
Decreased Immunologic Activity [PE]; Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]; mTOR Inhibitor Immunosuppressant [EPC]; mTOR Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 55111-654-01 | 55111065401 | 100 TABLET in 1 BOTTLE (55111-654-01) |
| 55111-654-30 | 55111065430 | 30 TABLET in 1 BOTTLE (55111-654-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/2e6130e5-fa94-dcf8-605c-817bf396e93dMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=55111-654NADAC price for package 55111065401
GET /v1/drugs/nadac/55111065401
Use it
Look up 55111-654 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/55111-654 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 55111-654. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.